Overview

Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia

Status:
Unknown status
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to assess the effects of 4 g/d P-OM3, compared with placebo, on LDL-C and other aspects of the fasting lipid profile in subjects with primary hypercholesterolemia.
Phase:
Phase 4
Details
Lead Sponsor:
Provident Clinical Research
Collaborator:
GlaxoSmithKline